Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor

Brain Research

Volumn 1431, Issue , 2012, Pages 86-96

  Whone, Alan L ^a,b   Kemp, Kevin ^a   Sun, Mingzhu ^a   Wilkins, Alastair ^a   Scolding, Neil J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b University of Bristol The Burden Neurological Institute   (United Kingdom)

Author keywords

Bone marrow derived mesenchymal stem cell (MSC); Dopaminergic neuron; Glial derived neurotrophic factor (GDNF); Noradrenergic neuron; Parkinson's disease; Serotonergic neuron

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER TRANSPORTER; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CATECHOLAMINE NERVE CELL; CELL COMMUNICATION; CELL SURVIVAL; CYTOKINE RELEASE; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NEUROPROTECTION; NONHUMAN; NORADRENERGIC NERVE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANALYSIS OF VARIANCE; ANIMALS; CATECHOLAMINES; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; EMBRYO, MAMMALIAN; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MESENCHYMAL STEM CELLS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NITRIC OXIDE; OXIDATIVE STRESS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PREGNANCY; RATS; SEROTONIN; TIME FACTORS;

RATTUS;

EID: 84855682242     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.10.038     Document Type: Article

References (54)

1. S. Arnhold, H. Klein, F.J. Klinz, Y. Absenger, A. Schmidt, T. Schinkothe, K. Brixius, J. Kozlowski, B. Desai, W. Bloch, and K. Addicks Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system Eur. J. Cell Biol. 85 2006 551 565
2. R. Barzilay, I. Kan, T. Ben-Zur, S. Bulvik, E. Melamed, and D. Offen Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols Stem Cells Dev. 17 2008 547 554 (Pubitemid 351948195)
3. K.D. Beck, J. Valverde, T. Alexi, K. Poulsen, B. Moffat, R.A. Vandlen, A. Rosenthal, and F. Hefti Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain Jan 26 Nature 373 6512 1995 339 341
4. H.M. Blau A twist of fate Nature 419 2002 437
5. G. Bouchez, L. Sensebe, P. Vourc'h, L. Garreau, S. Bodard, A. Rico, D. Guilloteau, P. Charbord, J.C. Besnard, and S. Chalon Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease Neurochem. Int. 52 2008 1332 1342
6. A. Brazzini, R. Cantella, A. De la Cruz, J. Yupanqui, C. Leon, T. Jorquiera, M. Brazzini, M. Ortega, and L.N. Saenz Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease J. Vasc. Interv. Radiol. 21 2010 443 451
7. C.R. Cogle, A.T. Yachnis, E.D. Laywell, D.S. Zander, J.R. Wingard, D.A. Steindler, and E.W. Scott Bone marrow transdifferentiation in brain after transplantation: a retrospective study Lancet 363 2004 1432 1437 (Pubitemid 38586719)
8. L. Crigler, R.C. Robey, A. Asawachaicharn, D. Gaupp, and D.G. Phinney Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis Exp. Neurol. 198 2006 54 64 (Pubitemid 43243744)
9. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317 (Pubitemid 44269669)
10. A. Ducray, S.H. Krebs, B. Schaller, R.W. Seiler, M. Meyer, and H.R. Widmer GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon Brain Res. 1069 2006 104 112 (Pubitemid 43149274)
11. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 Pt 5 1991 2283 2301
12. P. Gaspar, C. Duyckaerts, C. Alvarez, F. Javoy-Agid, and B. Berger Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease Ann. Neurol. 30 1991 365 374
13. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 5 2003 589 595 (Pubitemid 36597106)
14. D. Gordon, G. Pavlovska, J.B. Uney, D.C. Wraith, and N.J. Scolding Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis J. Neuropathol. Exp. Neurol. 69 2010 1087 1095
15. R. Grondin, Z. Zhang, A. Yi, W.A. Cass, N. Maswood, A.H. Andersen, D.D. Elsberry, M.C. Klein, G.A. Gerhardt, and D.M. Gash Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys Brain 125 2002 2191 2201
16. G.M. Halliday, P.C. Blumbergs, R.G. Cotton, W.W. Blessing, and L.B. Geffen Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease Brain Res. 510 1990 104 107 (Pubitemid 20060808)
17. K.A. Jellinger Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway Mol. Chem. Neuropathol. 14 1991 153 197
18. K. Kemp, E. Gray, E. Mallam, N. Scolding, and A. Wilkins Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells Stem Cell Rev. 6 2010 548 559
19. K. Kemp, K. Hares, E. Mallam, K.J. Heesom, N. Scolding, and A. Wilkins Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival J. Neurochem. 114 2010 1569 1580
20. K. Kemp, E. Mallam, N. Scolding, and A. Wilkins Stem cells in genetic myelin disorders Regen. Med. 5 2010 425 439
21. K. Kemp, D. Gordon, D.C. Wraith, E. Mallam, E. Hartfield, J. Uney, A. Wilkins, and N. Scolding Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells Neuropathol. Appl. Neurobiol. 37 2011 166 178
22. Y.J. Kim, H.J. Park, G. Lee, O.Y. Bang, Y.H. Ahn, E. Joe, H.O. Kim, and P.H. Lee Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action Glia 57 2009 13 23
23. S.H. Koh, K.S. Kim, M.R. Choi, K.H. Jung, K.S. Park, Y.G. Chai, W. Roh, S.J. Hwang, H.J. Ko, Y.M. Huh, H.T. Kim, and S.H. Kim Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats Brain Res. 1229 2008 233 248
24. M. Korbling, and Z. Estrov Adult stem cells for tissue repair - a new therapeutic concept? N. Engl. J. Med. 349 2003 570 582 (Pubitemid 36951370)
25. J.H. Kordower, M.E. Emborg, J. Bloch, S.Y. Ma, Y. Chu, L. Leventhal, J. McBride, E.Y. Chen, S. Palfi, B.Z. Roitberg, W.D. Brown, J.E. Holden, R. Pyzalski, M.D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon, and P. Aebischer Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767 773
26. A.E. Lang, S. Gill, N.K. Patel, A. Lozano, J.G. Nutt, R. Penn, D.J. Brooks, G. Hotton, E. Moro, P. Heywood, M.A. Brodsky, K. Burchiel, P. Kelly, A. Dalvi, B. Scott, M. Stacy, D. Turner, V.G. Wooten, W.J. Elias, E.R. Laws, V. Dhawan, A.J. Stoessl, J. Matcham, R.J. Coffey, and M. Traub Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann. Neurol. 59 2006 459 466 (Pubitemid 43358066)
27. P.H. Lee, and H.J. Park Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy J. Clin. Neurol. 5 2009 1 10
28. P.H. Lee, J.W. Kim, O.Y. Bang, Y.H. Ahn, I.S. Joo, and K. Huh Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy Clin. Pharmacol. Ther. 83 2008 723 730 (Pubitemid 351556019)
29. Y.S. Levy, M. Bahat-Stroomza, R. Barzilay, A. Burshtein, S. Bulvik, Y. Barhum, H. Panet, E. Melamed, and D. Offen Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease Cytotherapy 10 2008 340 352 (Pubitemid 351983158)
30. L.F. Lin, D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132 (Pubitemid 23186789)
31. S. Love, P. Plaha, N.K. Patel, G.R. Hotton, D.J. Brooks, and S.S. Gill Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain Nat. Med. 11 2005 703 704 (Pubitemid 41021193)
32. A.K. Meyer, M. Maisel, A. Hermann, K. Stirl, and A. Storch Restorative approaches in Parkinson's Disease: Which cell type wins the race? J. Neurol. Sci. 289 1-2 2009 93 103
33. E. Mezey, S. Key, G. Vogelsang, I. Szalayova, G.D. Lange, and B. Crain Transplanted bone marrow generates new neurons in human brains Proc. Natl. Acad. Sci. U. S. A. 100 2003 1364 1369 (Pubitemid 36184007)
34. T.C. Moloney, G.E. Rooney, F.P. Barry, L. Howard, and E. Dowd Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain Brain Res. 1359 2010 33 43
35. R.Y. Moore, A.L. Whone, and D.J. Brooks Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study Neurobiol. Dis. 29 2008 381 390
36. D. Offen, Y. Barhum, Y.S. Levy, A. Burshtein, H. Panet, T. Cherlow, and E. Melamed Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease Suppl. J. Neural Transm. 2007 133 143
37. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, M.F. Brin, K.M. Shannon, G.M. Nauert, D.P. Perl, J. Godbold, and T.B. Freeman A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann. Neurol. 54 2003 403 414 (Pubitemid 37072046)
38. H.J. Park, P.H. Lee, O.Y. Bang, G. Lee, and Y.H. Ahn Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease J. Neurochem. 107 2008 141 151
39. A. Pascual, M. Hidalgo-Figueroa, J.I. Piruat, C.O. Pintado, R. Gomez-Diaz, and J. Lopez-Barneo Absolute requirement of GDNF for adult catecholaminergic neuron survival Nat. Neurosci. 11 2008 755 761 (Pubitemid 351896676)
40. A.L. Peterson, and J.G. Nutt Treatment of Parkinson's disease with trophic factors Neurotherapeutics 5 2008 270 280 (Pubitemid 351454059)
41. P. Piccini, D.J. Brooks, A. Bjorklund, R.N. Gunn, P.M. Grasby, O. Rimoldi, P. Brundin, P. Hagell, S. Rehncrona, H. Widner, and O. Lindvall Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient Nat. Neurosci. 2 1999 1137 1140 (Pubitemid 30126374)
42. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147 (Pubitemid 29282067)
43. K. Pong, R.Y. Xu, K.D. Beck, T.J. Zhang, and J.C. Louis Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons Sep J. Neurochem. 69 3 1997 986 994 (Pubitemid 27364818)
44. K. Pong, R.Y. Xu, W.F. Baron, J.C. Louis, and K.D. Beck Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons Nov J. Neurochem. 71 5 1998 1912 1919 (Pubitemid 28491546)
45. N. Quinn, R.A. Barker, and G.K. Wenning Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? Clin. Pharmacol. Ther. 83 2008 663 665 (Pubitemid 351556024)
46. C.M. Rice, and N.J. Scolding Adult stem cells-reprogramming neurological repair? Lancet 364 2004 193 199 (Pubitemid 38891691)
47. C.M. Rice, and N.J. Scolding Autologous bone marrow stem cells-properties and advantages J. Neurol. Sci. 265 2008 59 62
48. N. Scolding, D. Marks, and C. Rice Autologous mesenchymal bone marrow stem cells: practical considerations J. Neurol. Sci. 265 2008 111 115
49. A. Shintani, N. Nakao, K. Kakishita, and T. Itakura Protection of dopamine neurons by bone marrow stromal cells Brain Res. 1186 2007 48 55
50. X. Wang, H. Willenbring, Y. Akkari, Y. Torimaru, M. Foster, M. Al-Dhalimy, E. Lagasse, M. Finegold, S. Olson, and M. Grompe Cell fusion is the principal source of bone-marrow-derived hepatocytes Nature 422 2003 897 901 (Pubitemid 36520042)
51. A.L. Whone, and N.J. Scolding Mesenchymal stem cells and neurodegenerative disease Clin. Pharmacol. Ther. 85 2009 19 20
52. A.L. Whone, R.Y. Moore, P.P. Piccini, and D.J. Brooks Plasticity of the nigropallidal pathway in Parkinson's disease Ann. Neurol. 53 2003 206 213 (Pubitemid 36164002)
53. A. Wilkins, K. Kemp, M. Ginty, K. Hares, E. Mallam, and N. Scolding Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro Stem Cell Res. 3 1 2009 63 70
54. R.M. Zweig, J.E. Cardillo, M. Cohen, S. Giere, and J.C. Hedreen The locus ceruleus and dementia in Parkinson's disease Neurology 43 1993 986 991 (Pubitemid 23150574)